ChromaDex Corporation Reports First Quarter 2023 Financial Results

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #earnings--ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the first quarter of 2023. First Quarter 2023 and Recent Highlights Total net sales were $22.6 million, up 31% from the prior year quarter, with $17.6 million from Tru Niagen®. Strong gross margin of 59.9% and a $2.8...

Click to view original post